Glenmede Trust’s Cymabay Therapeutics CBAY Stock Holding History

Glenmede Trust’s Portfolio CBAY Stock Details CBAY Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell
2023 Q4	$694K	Sell
2023 Q3	$565K	Buy
2020 Q4	–	Sell
2020 Q3	$1K	Buy